Recent Advances in Heat Transfer Enhancements: A Review Report

Different heat transfer enhancers are reviewed. They are (a) fins and microfins, (b) porous media, (c) large particles suspensions, (d) nanofluids, (e) phase-change devices, (f) flexible seals, (g) flexible complex seals, (h) vortex generators, (i) protrusions, and (j) ultra high thermal conductivity composite materials. Most of heat transfer augmentation methods presented in the literature that assists fins and microfins in enhancing heat transfer are reviewed. Among these are using joint-fins, fin roots, fin networks, biconvections, permeable fins, porous fins, capsulated liquid metal fins, and helical microfins. It is found that not much agreement exists between works of the different authors regarding single phase heat transfer augmented with microfins. However, too many works having sufficient agreements have been done in the case of two phase heat transfer augmented with microfins. With respect to nanofluids, there are still many conflicts among the published works about both heat transfer enhancement levels and the corresponding mechanisms of augmentations. The reasons beyond these conflicts are reviewed. In addition, this paper describes flow and heat transfer in porous media as a well-modeled passive enhancement method. It is found that there are very few works which dealt with heat transfer enhancements using systems supported with flexible/flexible-complex seals. Eventually, many recent works related to passive augmentations of heat transfer using vortex generators, protrusions, and ultra high thermal conductivity composite material are reviewed. Finally, theoretical enhancement factors along with many heat transfer correlations are presented in this paper for each enhancer

Comparative post-rainy season surveys of malaria-associated morbidity among febrile pediatric patients in Nouakchott, Mauritania

International audienc

Efficacy of chloroquine for the treatment of Plasmodium vivax in the Saharan zone in Mauritania

Background: In 2006, the Mauritanian Ministry of Health adopted a new therapeutic strategy based on the systematic use of artemisinin-based combination therapy (ACT), artesunate-amodiaquine and artemether-lumefantrine, for the first-and second-line treatment of uncomplicated malaria, respectively, regardless of Plasmodium spp. In the Saharan zone of the country, recent studies have shown that Plasmodium vivax largely predominates over Plasmodium falciparum. Anti-malarial drug response of P. vivax has not been evaluated in Mauritania. The aim of the present study was to evaluate the clinical efficacy and tolerance of chloroquine to treat P. vivax malaria in Mauritanian patients. Methods: Plasmodium vivax-infected patients aged > 6 months old were enrolled in Nouakchott and Atar in September-October 2013. Chloroquine was administered at the standard dose of 25 mg base/kg body weight over three days. Patients were followed until day 28, according to the standard 2009 World Health Organization protocol. Results: A total of 128 patients (67 in Nouakchott and 61 in Atar) were enrolled in the study. Seven patients (5.5%) were either excluded or lost to follow-up. Based on the per protocol analysis, chloroquine efficacy (adequate clinical and parasitological response) was 100%. Treatment was well-tolerated. One patient was excluded on day 1 due to urticaria and treated with artesunate-amodiaquine. Conclusions: Although the current national treatment guideline recommends artesunate-amodiaquine for the first-line treatment of uncomplicated malaria, including P. vivax malaria, chloroquine may still have an important role to play in anti-malarial chemotherapy in Mauritania. Further epidemiological studies are required to map the distribution of P. vivax and P. falciparum in the country